NCT03570203

Brief Summary

This study was designed to quantify the incidence of hyponatremia in patients of supratentorial/supra-sellar lesions and observe their effect on neurological morbidity and mortality.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
173

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2013

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 15, 2013

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2014

Completed
4.1 years until next milestone

First Submitted

Initial submission to the registry

June 14, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 26, 2018

Completed
Last Updated

June 26, 2018

Status Verified

June 1, 2018

Enrollment Period

5 months

First QC Date

June 14, 2018

Last Update Submit

June 25, 2018

Conditions

Keywords

HyponatremiaDysnatremiaNeurosurgeryNeurointensive Care

Outcome Measures

Primary Outcomes (1)

  • Mortality

    To observe relationship between hyponatremia in supratentorial tumor patients and in-hospital mortality.

    From date of admission to hospital to date of Discharge from hospital or Death in hospital, whichever comes first, assessed up to 2 years from date of admission.

Secondary Outcomes (4)

  • Duration of hospital stay

    From date of admission to hospital to date of Discharge from hospital or Death in hospital, whichever comes first, assessed up to 2 years from date of admission.

  • Rate of admission in intensive care unit.

    From date of admission to hospital to date of Discharge from hospital or Death in hospital, whichever comes first, assessed up to 2 years from date of admission.

  • Neurological deficits

    From date of admission to hospital to date of Discharge from hospital or Death in hospital, whichever comes first, assessed up to 2 years from date of admission.

  • Seizures

    From date of admission to hospital to date of Discharge from hospital or Death in hospital, whichever comes first, assessed up to 2 years from date of admission.

Study Arms (2)

Retrospective Cohort

Supratentorial/Suprasellar brain tumor patients with Glasgow Coma Score \> 3 at time of admission.

Diagnostic Test: Serum Sodium

Prospective Cohort

Supratentorial/Suprasellar brain tumor patients with Glasgow Coma Score \> 3 at time of recruitment.

Diagnostic Test: Serum Sodium

Interventions

Serum SodiumDIAGNOSTIC_TEST

Measurement of serum sodium.

Prospective CohortRetrospective Cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients admitted to NIMHANS for surgical management of Supratentorial/Suprasellar tumor management with GCS \> 3 at recruitment (for prospective cohort) or admission (for retrospective cohort).

You may qualify if:

  • Patients undergoing surgical management for supratentorial/suprasellar tumors.

You may not qualify if:

  • Glasgow Coma Score (GCS) \<4.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hyponatremia

Condition Hierarchy (Ancestors)

Water-Electrolyte ImbalanceMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 14, 2018

First Posted

June 26, 2018

Study Start

December 15, 2013

Primary Completion

April 30, 2014

Study Completion

April 30, 2014

Last Updated

June 26, 2018

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will not share